Adaptive Biotechnologies Corporation: shareholders and insiders

ADPTNASDAQHealthcare · Biological Products, (No Diagnostic Substances)

Price

$29.23

November 19, 2026Market cap $4.7B

What Ploutos Investor adds for Adaptive Biotechnologies

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 9 fiscal years, from 2017
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Insiders and their shares

Purchases and sales by officers and directors from Nov 19, 2025 to Nov 13, 2026, from their own Form 4 filings.

37 Form 4s

Bought on the market

–

nobody

Sold on the market

$127M

11 people

From Nov 19, 2025 to Nov 19, 2026, the days the chart shows. Change its range and the figures follow.

How the sales were made, as a share of their value

  • Under a set plan77%
  • The rest23%

By year

Insiders' open-market purchases (up) and sales (down), by value, since Nov 19, 2025, on a log scale: each gridline is ten times the last. From the SEC's quarterly data sets of Form 4 filings.

2026·no buys·sold $108M by 11 people

  • 2025: no buys, sold $19M by 6 people
  • 2026: no buys, sold $108M by 11 people
  • Nov 13, 2026Julie RubinsteinPresident and COO
    Kind10b5-1
  • Nov 13, 2026Julie RubinsteinPresident and COO
    Kind10b5-1
  • Nov 12, 2026Julie RubinsteinPresident and COO
    Kind10b5-1
  • Nov 12, 2026Julie RubinsteinPresident and COO
    Kind10b5-1
  • Nov 11, 2026Julie RubinsteinPresident and COO
    Kind10b5-1
  • Nov 11, 2026Julie RubinsteinPresident and COO
    Kind10b5-1
  • Nov 11, 2026Julie RubinsteinPresident and COO
    Kind10b5-1
  • Nov 11, 2026Susan BobulskyChief Commercial Officer, MRD
    Kind10b5-1
  • Nov 10, 2026Julie RubinsteinPresident and COO
    Kind10b5-1
  • Nov 10, 2026Julie RubinsteinPresident and COO
    Kind10b5-1
  • Nov 10, 2026Julie RubinsteinPresident and COO
    Kind10b5-1
  • Nov 9, 2026Chad M RobinsCEO and Chairman
    Kind
  • Nov 9, 2026Julie RubinsteinPresident and COO
    Kind10b5-1
  • Nov 9, 2026Julie RubinsteinPresident and COO
    Kind10b5-1
  • Nov 9, 2026Julie RubinsteinPresident and COO
    Kind10b5-1
  • Nov 9, 2026Julie RubinsteinPresident and COO
    Kind10b5-1
  • Nov 6, 2026Julie RubinsteinPresident and COO
    Kind10b5-1
  • Nov 6, 2026Julie RubinsteinPresident and COO
    Kind10b5-1
  • Nov 6, 2026Julie RubinsteinPresident and COO
    Kind10b5-1
  • Nov 5, 2026Julie RubinsteinPresident and COO
    Kind10b5-1
  • Nov 5, 2026Julie RubinsteinPresident and COO
    Kind10b5-1
  • Nov 5, 2026Julie RubinsteinPresident and COO
    Kind10b5-1
  • Nov 5, 2026Julie RubinsteinPresident and COO
    Kind10b5-1
  • Nov 4, 2026Julie RubinsteinPresident and COO
    Kind10b5-1
  • Nov 4, 2026Julie RubinsteinPresident and COO
    Kind10b5-1

From the Form 4s insiders file with the SEC within two business days of each trade. Before Jun 8, 2026 the table lists open-market purchases and sales only (no grants, option exercises or tax withholding), from the SEC's quarterly data sets. The 10b5-1 mark comes from the form's own box (since April 2023) or from a footnote of the filing that names the plan, where there is one.

Insiders and their shares

Every buy and sale by ADPT's officers and directors from 2019 up to November 18, 2025, 7 more calendar years

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 3 years.

Major holders (over 5%)

Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.

2 Holders over 5%May 15, 2026 Latest filing
  • Viking Global Investorswith 7 more persons
    Share of class18.8%
  • BlackRock, Inc.
    Share of class7.90%
Fell to 5% or less (6)

Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.

  • The Vanguard Group0.00%Mar 26, 202613G/A
  • Rubric Capital Management LP4.12%Jul 9, 202513G/A
  • ARK Investment Management LLC2.90%Jun 6, 202513G/A
  • Nikko Asset Management Americas, Inc.4.63%Feb 13, 202513G/A
  • Sumitomo Mitsui Trust Group, Inc.4.60%Feb 4, 202513G/A
  • Integrated Core Strategies (US) LLC4.30%Jan 27, 202513G/A

From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.

Well-known managers

Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.

Sep 30, 2026 quarter end
  • Viking Global (Halvorsen)
    In the quarter
  • D.E. Shaw
    In the quarter+38%
  • Point72 (Cohen)
    In the quarter
  • Millennium Mgmt (Englander)
    In the quarter+141%
  • Renaissance Technologies
    In the quarter+186%
  • Bridgewater (Dalio)
    In the quarter+79%
  • Citadel Advisors (Griffin)
    In the quarter+29%
  • AQR Capital
    In the quarter+43%

From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).

Short interest

How many of the company's shares have been sold borrowed and not yet bought back, twice a month.

On Oct 15, 2026, 7.41% of its shares outstanding were held short, +1.3% since the report before.

Shares held short
11.99M
7.41%
Since the report before11.84M on Sep 30, 2026
+1.3%
5.0
2.38M
More days to cover thanof 4,578 US-listed companies with enough volume
61%
Report date
Oct 15, 2026
  • Oct 31, 2023: Shares held short 10.74M
  • Nov 15, 2023: Shares held short 11.23M
  • Nov 30, 2023: Shares held short 10.49M
  • Dec 15, 2023: Shares held short 9.58M
  • Dec 29, 2023: Shares held short 9.46M
  • Jan 12, 2024: Shares held short 8.76M
  • Jan 31, 2024: Shares held short 8.81M
  • Feb 15, 2024: Shares held short 9.19M
  • Feb 29, 2024: Shares held short 8.77M
  • Mar 15, 2024: Shares held short 8.46M
  • Mar 28, 2024: Shares held short 9.10M
  • Apr 15, 2024: Shares held short 10.01M
  • Apr 30, 2024: Shares held short 12.04M
  • May 15, 2024: Shares held short 13.14M
  • May 31, 2024: Shares held short 13.38M
  • Jun 14, 2024: Shares held short 13.05M
  • Jun 28, 2024: Shares held short 12.14M
  • Jul 15, 2024: Shares held short 11.91M
  • Jul 31, 2024: Shares held short 10.95M
  • Aug 15, 2024: Shares held short 9.66M
  • Aug 30, 2024: Shares held short 9.71M
  • Sep 13, 2024: Shares held short 9.63M
  • Sep 30, 2024: Shares held short 9.91M
  • Oct 15, 2024: Shares held short 9.48M
  • Oct 31, 2024: Shares held short 8.96M
  • Nov 15, 2024: Shares held short 8.20M
  • Nov 29, 2024: Shares held short 9.58M
  • Dec 13, 2024: Shares held short 9.03M
  • Dec 31, 2024: Shares held short 9.19M
  • Jan 15, 2025: Shares held short 8.66M
  • Jan 31, 2025: Shares held short 8.53M
  • Feb 14, 2025: Shares held short 8.78M
  • Feb 28, 2025: Shares held short 8.66M
  • Mar 14, 2025: Shares held short 9.49M
  • Mar 31, 2025: Shares held short 10.12M
  • Apr 15, 2025: Shares held short 9.89M
  • Apr 30, 2025: Shares held short 9.14M
  • May 15, 2025: Shares held short 9.10M
  • May 30, 2025: Shares held short 9.64M
  • Jun 13, 2025: Shares held short 8.93M
  • Jun 30, 2025: Shares held short 10.13M
  • Jul 15, 2025: Shares held short 9.69M
  • Jul 31, 2025: Shares held short 9.93M
  • Aug 15, 2025: Shares held short 8.95M
  • Aug 29, 2025: Shares held short 8.43M
  • Sep 15, 2025: Shares held short 9.34M
  • Sep 30, 2025: Shares held short 9.59M
  • Oct 15, 2025: Shares held short 9.03M
  • Oct 31, 2025: Shares held short 9.01M
  • Nov 14, 2025: Shares held short 10.37M
  • Nov 28, 2025: Shares held short 10.40M
  • Dec 15, 2025: Shares held short 9.74M
  • Dec 31, 2025: Shares held short 8.76M
  • Jan 15, 2026: Shares held short 9.02M
  • Jan 30, 2026: Shares held short 9.03M
  • Feb 13, 2026: Shares held short 9.19M
  • Feb 27, 2026: Shares held short 8.88M
  • Mar 13, 2026: Shares held short 9.25M
  • Mar 31, 2026: Shares held short 8.56M
  • Apr 15, 2026: Shares held short 8.55M
  • Apr 30, 2026: Shares held short 8.44M
  • May 15, 2026: Shares held short 8.90M
  • May 29, 2026: Shares held short 8.24M
  • Jun 15, 2026: Shares held short 7.65M
  • Jun 30, 2026: Shares held short 11.35M
  • Jul 15, 2026: Shares held short 11.40M
  • Jul 31, 2026: Shares held short 12.49M
  • Aug 14, 2026: Shares held short 13.32M
  • Aug 31, 2026: Shares held short 11.71M
  • Sep 15, 2026: Shares held short 13.49M
  • Sep 30, 2026: Shares held short 11.84M
  • Oct 15, 2026: Shares held short 11.99M

As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.

Short sales in daily trading46.9% of the shares in the last 14 sessions' reported trades were short sales.

In the last 14 sessions, 46.9% of the shares in the reported trades were short sales, against 46.7% in the 14 before.

Last 14 sessionsOct 30, 2026 – Nov 18, 2026
46.9%
The 14 beforeOct 12, 2026 – Oct 29, 2026
46.7%
Change
+0.2 pts
Short sales a dayon average, of 1.09M shares
510.4K
More than atof 3,656 US-listed companies, same days
38%
Median of alleight in ten from 34.4% to 63.7%
50.3%
  • Oct 12, 2026: Short sales 42.8%
  • Oct 13, 2026: Short sales 48.2%
  • Oct 14, 2026: Short sales 55.4%
  • Oct 15, 2026: Short sales 20.8%
  • Oct 16, 2026: Short sales 43.8%
  • Oct 19, 2026: Short sales 47.7%
  • Oct 20, 2026: Short sales 41.3%
  • Oct 21, 2026: Short sales 69%
  • Oct 22, 2026: Short sales 65.4%
  • Oct 23, 2026: Short sales 50.5%
  • Oct 26, 2026: Short sales 47%
  • Oct 27, 2026: Short sales 43.2%
  • Oct 28, 2026: Short sales 43.1%
  • Oct 29, 2026: Short sales 46%
  • Oct 30, 2026: Short sales 58.3%
  • Nov 2, 2026: Short sales 34%
  • Nov 3, 2026: Short sales 31.8%
  • Nov 4, 2026: Short sales 44.7%
  • Nov 5, 2026: Short sales 28.3%
  • Nov 6, 2026: Short sales 52.6%
  • Nov 9, 2026: Short sales 40.4%
  • Nov 10, 2026: Short sales 48.9%
  • Nov 11, 2026: Short sales 54.8%
  • Nov 12, 2026: Short sales 50.5%
  • Nov 13, 2026: Short sales 52%
  • Nov 16, 2026: Short sales 28.3%
  • Nov 17, 2026: Short sales 49.9%
  • Nov 18, 2026: Short sales 72.4%

This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.

What the insiders hold

The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.

5.61M Insiders' shares3.64% Of the company
  • Chad M RobinsCEO and Chairman
    Directly2.08M
  • Harlan S RobinsChief Scientific Officer
    Directly1.03M
  • Tycho PetersonChief Financial Officer
    Directly531.6K
  • Susan BobulskyChief Commercial Officer, MRD
    Directly387.5K
  • Julie RubinsteinPresident and COO
    Directly377.8K
  • Kyle PiskelChief Financial Officer
    Directly256.7K
  • Peter M NeupertDirector
    Directly240.3K
  • Francis LoChief People Officer
    Directly223.4K
  • Sharon BenzenoChief Commercial Ofc Imm Med
    Directly221.3K
  • Stacy L TaylorSVP and General Counsel
    Directly139.4K
  • Katey Einterz OwenDirector
    Directly66.1K
  • Robert HershbergDirector
    Directly46.7K
  • Michelle Renee GriffinDirector
    Directly15.6K

A lower bound: it counts only the 13 officers and directors with a market trade since Nov 20, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.

The ETFs that hold it

Which of the 345 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.

16 ETFs holding it2.57% The largest weight (ARKG)
  • ARKGARK Genomic Revolution ETF
    Weight in the fund2.57%
  • IBBiShares Biotechnology ETF
    Weight in the fund0.26%
  • FESMFidelity Enhanced Small Cap Core ETF
    Weight in the fund0.24%
  • IWOiShares Russell 2000 Growth ETF
    Weight in the fund0.20%
  • VTWOVanguard Russell 2000 Index Fund
    Weight in the fund0.12%
  • IWMiShares Russell 2000 ETF
    Weight in the fund0.10%
  • SCHASchwab U.S. Small-Cap ETF
    Weight in the fund0.06%
  • VBKVanguard Small-Cap Growth Index Fund
    Weight in the fund0.05%
  • VHTVanguard Health Care Index Fund
    Weight in the fund0.04%
  • VXFVanguard Extended Market Index Fund
    Weight in the fund0.03%

16 of the 345 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.

Institutional investors by quarter

Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.

301 Managers, Q2 2026$3.3B Value of their positions
  • Q3 2025: Managers 271
  • Q4 2025: Managers 283
  • Q1 2026: Managers 300
  • Q2 2026: Managers 301

Institutional investors by quarter

The fund managers holding ADPT, quarter by quarter, from Q1 2016 to Q2 2025, 29 more quarters

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 12 quarters.

Q2 2026: 301 managers held 156M shares, worth $3.3B. During the quarter 49 opened a position, 48 closed one, 107 added and 86 trimmed.

The largest holders, Q2 2026

  • Viking Global (Halvorsen)
    In the quarter
  • BlackRock
    In the quarter+14%
  • Vanguard Capital Management
    In the quarter+5.1%
  • Wellington Management Group
    In the quarter+53%
  • Vanguard Portfolio Management
    In the quarter+22%
  • D.E. Shaw
    In the quarter+135%
  • Westfield Capital Management
    In the quarter-22%
  • Geode Capital Management
    In the quarter+0.2%
  • State Street
    In the quarter+7.2%
  • Invesco
    In the quarter-30%

From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.

Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.

The full analysis

What do Adaptive Biotechnologies's filings show?

Who buys and sells is one part of Adaptive Biotechnologies's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about ADPT's shareholders

Didn't find what you were looking for?

Ask us
Have ADPT's insiders bought or sold?

From Jun 8, 2026 to Nov 13, 2026 Adaptive Biotechnologies's insiders bought 0 and sold $65M of shares on the market. 71% of the sales were under set 10b5-1 plans.

Which well-known managers hold ADPT?

8 of the managers we track held the shares on Sep 30, 2026. The largest position was Viking Global (Halvorsen)'s, worth $867M.

Is every insider transaction a purchase or a sale?

No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.